Cargando…
A Pilot Study Examining the Prognostic Utility of Tumor Shrinkage on Cone-Beam Computed Tomography (CBCT) for Stage III Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Definitive Chemoradiation
There has been growing interest in utilizing information from cone-beam computed tomography (CBCT) to help guide both treatment delivery and prognosis. In this assessment of locally advanced unresectable stage III non-small cell lung cancer (NSCLC) treated with definitive chemoradiation, we aimed to...
Autores principales: | Kang, Kylie H., Efird, Jimmy T., Podder, Tarun K., Zhang, Yuxia, Dowlati, Afshin, Machtay, Mitchell, Jindal, Charulata, Biswas, Tithi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004060/ https://www.ncbi.nlm.nih.gov/pubmed/33801033 http://dx.doi.org/10.3390/ijerph18063241 |
Ejemplares similares
-
Cone beam computed tomography—the need for future guidance
por: Efird, Jimmy T., et al.
Publicado: (2022) -
Pretreatment neutrophil-to-lymphocyte ratio as an important prognostic marker in stage III locally advanced non-small cell lung cancer: confirmatory results from the PROCLAIM phase III clinical trial
por: Biswas, Tithi, et al.
Publicado: (2021) -
On the Frontiers of Breast Cancer Diagnosis and Treatment: Current and Future Directions in a Rapidly Changing Field
por: Efird, Jimmy T., et al.
Publicado: (2022) -
Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
por: Biswas, Tithi, et al.
Publicado: (2020) -
Dermatological Autoimmune Considerations of Immune Checkpoint Therapy
por: Fane, Lauren S., et al.
Publicado: (2022)